Danielle DicaraPrincipal Scientific Researcher, Antibody Engineering at Genentech
Danielle’s research interests focus on molecule targeting for therapeutic and/or diagnostic purposes, with an emphasis on LM design, selection, engineering and characterization. She completed her BA in Natural Sciences at the University of Cambridge and obtained her PhD at the Centre for Tumour Biology at Queen Mary University of London. This was followed by post-doctoral work at the William Harvey Institute in London at the Centre for Experimental Medicine & Rheumatology and subsequently at the University of Cambridge Department of Oncology. Currently she does drug discovery research in the Antibody Engineering department at Genentech, which she joined in 2012.